BC264
BC264 is a highly potent and selective CCK-B agonist that crosses the blood-brain barrier. BC264 increases dopamine in the nucleus accumbens and facilitates motivation and attention in rats[1].
Product Specifications
UNSPSC
12352211
Target
Cholecystokinin Receptor
Related Pathways
GPCR/G Protein; Neuronal Signaling
Field of Research
Neurological Disease
Smiles
NC([C@H](CC1=CC=CC=C1)NC([C@H](CC(O)=O)NC([C@H](CCCC)N(C)C([C@@H](NC(CNC([C@H](CCCC)NC([C@H](CCSC)NC([C@H](CC2=CC=C(S(=O)(O)=O)C=C2)NC(OC(C)(C)C)=O)=O)=O)=O)=O)CC3=CNC4=C3C=CC=C4)=O)=O)=O)=O
Molecular Formula
C58H80N10O15S2
Molecular Weight
1221.44
References & Citations
[1]Ladurelle N, et al. The CCK-B agonist, BC264, increases dopamine in the nucleus accumbens and facilitates motivation and attention after intraperitoneal injection in rats. Eur J Neurosci. 1997 Sep;9 (9) :1804-14.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CCKBR
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
D6257 96 Tests
Gap junction gamma-2 protein (GJC2) Bovine ELISA Kit
Sign In for Pricing
View Details 
MBS6307357-01 0.1 mL
HMGN5, NT (HMGN5, NSBP1, High mobility group nucleosome-binding domain-containing protein 5, Nucleosome-binding protein 1) (MaxLight 405)
Sign In for Pricing
View Details MBS6307357-02 5x 0.1 mL
HMGN5, NT (HMGN5, NSBP1, High mobility group nucleosome-binding domain-containing protein 5, Nucleosome-binding protein 1) (MaxLight 405)
Sign In for Pricing
View Details